TBVI Releases 2009 Annual Report

5 Jul 2010
by Working Group

From the TBVI website:

TBVI 2009 Annual Report
TBVI 2009 Annual Report

TuBerculosis Vaccine Initiative (TBVI), a foundation that aims to develop new vaccines for tuberculosis, today released its annual report 2009.

In 2009 TBVI made significant progress in its overall objective to develop new vaccines for tuberculosis. Preceded by many years of research and development, last year four vaccine candidates moved from discovery phase to early clinical development. Furthermore, TBVI expanded its network with several new research partners and completed the formation of its Board of Trustees.

Last year wealso successfully acquired new funding that has strengthened our organisation and secured continued support for R&D activities carried out by our partners.

The annual report gives a further overview of our advancements, our work and our partners.

Jelle Thole,
Director TBVI

More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...